988
HETEROCYCLES, Vol. 74, 2007
evaporated in vacuo. The residue was separated by column chromatography with 1:1 AcOEt-hexane to
give 5a (38.9 mg, 47%) and 6a (29.1 mg, 35%).
5a: Colorless syrup; Rf = 0.35 (D); [α]D +3.28° (c 2.02) [lit.,9 [α]D +5.50° (MeOH)]; H NMR17 δ =
1.57 (3H, dd, J2,3 = 5.4, J3,P = 1.0 Hz, H3-3), 2.95 (1H, dd, J1,P = 27.6, J1,2 = 4.4 Hz, H-1), 3.28 (1H, dqd,
J2,P = 6.4 Hz, H-2), 3.81, 3.83 [3H each, 2d, JPOMe = 10.9 Hz, P(OMe)2]; 13C NMR δ = 14.08 (C-3), 49.40
30
21
1
1
2
2
31
(d, J1,P = 205.0 Hz, C-1), 52.79, 53.21 [2d, JC,P = 6.3 Hz, P(OMe)2], 53.31 (d, J2,P = 1.7 Hz, C-2); P
NMR δ = 22.00.
6a: Colorless syrup; Rf = 0.28 (D); [α]D30 –18.3° (c 2.44); 1H NMR δ = 1.39 (3H, dd, J2,3 = 5.1, J3,P = 1.7
Hz, H3-3), 2.77 (1H, dd, J1,P = 31.0, J1,2 = 2.7 Hz, H-1), 3.29 (1H, dqd, J2,P = 5.4 Hz, H-2), 3.80, 3.81 [3H
each, 2d, JPOMe = 10.7 Hz, P(OMe)2]; 13C NMR δ = 17.44 (C-3), 50.68 (d, 1J1,P = 203.4 Hz, C-1), 52.86 (d,
2J2,P = 1.7 Hz, C-2), 53.13, 53.55 [2d, 2JC,P = 6.3 Hz, P(OMe)2]; 31P NMR δ = 21.18.
Procedures for Entry 8 in Table 1. To a solution of 4 (114 mg, 0.499 mmol) in dry CH2Cl2 (2.0 mL)
was added titanium isopropoxide (0.180 mL, 0.608 mmol) at –5 °C under argon. The mixture was
stirred at the same temperature for 40 min and then dimethyl phosphonate (0.070 mL, 0.76 mmol) was
added. After stirring at –5 °C for 10 h, DBU (0.150 mL, 1.00 mmol) was added and the mixture was
stirred at 20 °C for 3 h. Then, water (0.5 mL) was added and the resulting precipitate was filtered off
through Celite. The filtrate was diluted with water and extracted with CHCl3. The combined organic
layer was dried (Na2SO4) and evaporated in vacuo. The residue was separated by column
chromatography to give 5a (48.2 mg, 58%) and 6a (9.2 mg, 11%).
Dibenzyl (1R,2S)-1,2-epoxypropylphosphonate (5b) and its (1S,2S)-epimer (6b).
Procedures for Entry 10 in Table 1. The same procedures described above for Entry 8 were employed.
Thus, compound (4) (114 mg, 0.499 mmol) was treated with dibenzyl phosphonate (0.170 mL, 0.77
mmol) to give 5b (92.6 mg, 58%) and 6b (12.7 mg, 8%), after separation by column chromatography
with 1:2 AcOEt-hexane.
23
20
1
5b: Colorless syrup; Rf = 0.40 (C); [α]D +5.04° (c 1.67) [lit.,11 [α]D +4.4° (CDCl3)]; H NMR17 δ =
1.56 (3H, d, J2,3 = 5.6 Hz, H3-3), 2.95 (1H, dd, J1,P = 28.1, J1,2 = 4.4 Hz, H-1), 3.24 (1H, dqd, J2,P = 6.4 Hz,
2
H-2), 5.03, 5.09 [1H each, 2dd, 2JCH2 = 11.7, JPOCH = 8.3 Hz, POCH2], 5.10, 5.13 [1H each, 2dd, JCH2
=
11 7, JPOCH = 8.8 Hz, POCH2], 7.32–7.38 (10H, m, Ph); 13C NMR δ = 14.11 (C-3), 50.13 (d, 1J1,P = 204.4
2
2
Hz, C-1), 53.67 (d, J2,P = 1.7 Hz, C-2), 67.76, 68.15 [2d, JC,P = 6.3 Hz, POCH2], 128.03, 128.09 [2s,
Ph(o)], 128.55, 128.60 [2s, Ph(p)], 128.60, 128.61 [2s, Ph(m)], 135.81, 135.89* [2d, JC,P = 5.8, 6.3* Hz,
3
Ph(ipso)]; 31P NMR δ = 22.56.
6b: Colorless syrup; Rf = 0.33 (C); [α]D –11.3° (c 2.27); 1H NMR δ = 1.28 (3H, d, J2,3 = 5.1, J3,P = 1.8
23
Hz, H3-3), 2.71 (1H, dd, J1,P = 31.5, J1,2 = 2.5 Hz, H-1), 3.23 (1H, quintd, J2,P = 5.1 Hz, H-2), 5.04, 5.08
2
2
[1H each, 2dd, JCH2 = 11.7, JPOCH = 7.8 Hz, POCH2], 5.045, 5.09 [1H each, 2dd, JCH2 = 11.7, JPOCH
=
13
1
8.8 Hz, POCH2], 7.32–7.38 (10H, m, Ph); C NMR δ = 14.16 (C-3), 51.38 (d, J1,P = 202.1 Hz, C-1),
2
2
53.04 (d, J2,P = 1.2 Hz, C-2), 68.15, 68.31 [2d, JC,P = 6.3 Hz, POCH2], 128.01, 128.09 [2s, Ph(o)],
128.55, 128.62 [2s, Ph(p)], 128.60, 128.62 [2s, Ph(m)], 135.72, 135.86* [2d, JC,P = 6.3, 5.6* Hz,
3
Ph(ipso)]; 31P NMR δ = 19.89.